世界のバイオ医薬品CMO・CRO市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biopharmaceutical CMO & CRO Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0826 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、バイオ医薬品CMO・CROのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、バイオシミラー）、用途別市場規模（受託製造、受託研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオ医薬品CMO・CROの市場動向 ・企業の競争状況、市場シェア ・バイオ医薬品CMO・CROの種類別市場規模（生物製剤、バイオシミラー） ・バイオ医薬品CMO・CROの用途別市場規模（受託製造、受託研究） ・バイオ医薬品CMO・CROの北米市場規模2016-2027（アメリカ、カナダ） ・バイオ医薬品CMO・CROのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオ医薬品CMO・CROのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオ医薬品CMO・CROの中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオ医薬品CMO・CROの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lonza、Boehringer Ingelheim GmbH、Rentschler Biotechnologie GmbH、Inno Biologics Sdn Bhd、JRS Pharma (Celonic GmbH)、BIOMEVA GmbH、ProBioGen、FUJIFILM Diosynth Biotechnologies U.S.A., Inc.、TOYOBO CO., LTD、Samsung BioLogics、Patheon、CMC Biologics、Binex Co., Ltd.、AbbVie Inc.、WuXi Biologics.） ・結論

Key factors that are driving the biopharmaceutical CMO & CRO market growth include the rise in investment by CMOs for capacity expansion, the commercial success of biopharmaceuticals, and consequent increase in demand for biopharmaceuticals, and robust biopharmaceuticals pipeline

Market Analysis and Insights: Global Biopharmaceutical CMO & CRO Market
The global Biopharmaceutical CMO & CRO market size is projected to reach US$ XX million by 2026, from US$ 2512 million in 2019, at a CAGR of 7.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical CMO & CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical CMO & CRO market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical CMO & CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical CMO & CRO market.

Global Biopharmaceutical CMO & CRO Scope and Market Size
Biopharmaceutical CMO & CRO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical CMO & CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biologics
Biosimilars

Segment by Application
Contract Manufacturing
Contract Research

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma (Celonic GmbH)
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
TOYOBO CO., LTD
Inno Biologics Sdn Bhd
JRS Pharma (Celonic GmbH)
CMC Biologics
Binex Co., Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics
1.2.3 Biosimilars
1.3 Market by Application
1.3.1 Global Biopharmaceutical CMO & CRO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Contract Manufacturing
1.3.3 Contract Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biopharmaceutical CMO & CRO Market Perspective (2016-2027)
2.2 Biopharmaceutical CMO & CRO Growth Trends by Regions
2.2.1 Biopharmaceutical CMO & CRO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceutical CMO & CRO Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceutical CMO & CRO Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceutical CMO & CRO Industry Dynamic
2.3.1 Biopharmaceutical CMO & CRO Market Trends
2.3.2 Biopharmaceutical CMO & CRO Market Drivers
2.3.3 Biopharmaceutical CMO & CRO Market Challenges
2.3.4 Biopharmaceutical CMO & CRO Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue
3.1.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceutical CMO & CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical CMO & CRO Revenue
3.4 Global Biopharmaceutical CMO & CRO Market Concentration Ratio
3.4.1 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO & CRO Revenue in 2020
3.5 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical CMO & CRO Product Solution and Service
3.7 Date of Enter into Biopharmaceutical CMO & CRO Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical CMO & CRO Breakdown Data by Type
4.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2022-2027)

5 Biopharmaceutical CMO & CRO Breakdown Data by Application
5.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biopharmaceutical CMO & CRO Market Size (2016-2027)
6.2 North America Biopharmaceutical CMO & CRO Market Size by Type
6.2.1 North America Biopharmaceutical CMO & CRO Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceutical CMO & CRO Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceutical CMO & CRO Market Size by Type (2016-2027)
6.3 North America Biopharmaceutical CMO & CRO Market Size by Application
6.3.1 North America Biopharmaceutical CMO & CRO Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceutical CMO & CRO Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceutical CMO & CRO Market Size by Application (2016-2027)
6.4 North America Biopharmaceutical CMO & CRO Market Size by Country
6.4.1 North America Biopharmaceutical CMO & CRO Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceutical CMO & CRO Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Biopharmaceutical CMO & CRO Market Size (2016-2027)
7.2 Europe Biopharmaceutical CMO & CRO Market Size by Type
7.2.1 Europe Biopharmaceutical CMO & CRO Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceutical CMO & CRO Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceutical CMO & CRO Market Size by Type (2016-2027)
7.3 Europe Biopharmaceutical CMO & CRO Market Size by Application
7.3.1 Europe Biopharmaceutical CMO & CRO Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceutical CMO & CRO Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceutical CMO & CRO Market Size by Application (2016-2027)
7.4 Europe Biopharmaceutical CMO & CRO Market Size by Country
7.4.1 Europe Biopharmaceutical CMO & CRO Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceutical CMO & CRO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biopharmaceutical CMO & CRO Market Size (2016-2027)
9.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type
9.2.1 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceutical CMO & CRO Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceutical CMO & CRO Market Size by Application
9.3.1 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceutical CMO & CRO Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceutical CMO & CRO Market Size by Country
9.4.1 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceutical CMO & CRO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biopharmaceutical CMO & CRO Introduction
11.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.1.5 Lonza Recent Development
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Details
11.2.2 Boehringer Ingelheim GmbH Business Overview
11.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Introduction
11.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.2.5 Boehringer Ingelheim GmbH Recent Development
11.3 Rentschler Biotechnologie GmbH
11.3.1 Rentschler Biotechnologie GmbH Company Details
11.3.2 Rentschler Biotechnologie GmbH Business Overview
11.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Introduction
11.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.3.5 Rentschler Biotechnologie GmbH Recent Development
11.4 Inno Biologics Sdn Bhd
11.4.1 Inno Biologics Sdn Bhd Company Details
11.4.2 Inno Biologics Sdn Bhd Business Overview
11.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Introduction
11.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.4.5 Inno Biologics Sdn Bhd Recent Development
11.5 JRS Pharma (Celonic GmbH)
11.5.1 JRS Pharma (Celonic GmbH) Company Details
11.5.2 JRS Pharma (Celonic GmbH) Business Overview
11.5.3 JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Introduction
11.5.4 JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.5.5 JRS Pharma (Celonic GmbH) Recent Development
11.6 BIOMEVA GmbH
11.6.1 BIOMEVA GmbH Company Details
11.6.2 BIOMEVA GmbH Business Overview
11.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Introduction
11.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.6.5 BIOMEVA GmbH Recent Development
11.7 ProBioGen
11.7.1 ProBioGen Company Details
11.7.2 ProBioGen Business Overview
11.7.3 ProBioGen Biopharmaceutical CMO & CRO Introduction
11.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.7.5 ProBioGen Recent Development
11.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
11.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Biopharmaceutical CMO & CRO Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
11.9 TOYOBO CO., LTD
11.9.1 TOYOBO CO., LTD Company Details
11.9.2 TOYOBO CO., LTD Business Overview
11.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Introduction
11.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.9.5 TOYOBO CO., LTD Recent Development
11.10 Samsung BioLogics
11.10.1 Samsung BioLogics Company Details
11.10.2 Samsung BioLogics Business Overview
11.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Introduction
11.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.10.5 Samsung BioLogics Recent Development
11.11 Patheon
11.11.1 Patheon Company Details
11.11.2 Patheon Business Overview
11.11.3 Patheon Biopharmaceutical CMO & CRO Introduction
11.11.4 Patheon Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.11.5 Patheon Recent Development
11.12 CMC Biologics
11.12.1 CMC Biologics Company Details
11.12.2 CMC Biologics Business Overview
11.12.3 CMC Biologics Biopharmaceutical CMO & CRO Introduction
11.12.4 CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.12.5 CMC Biologics Recent Development
11.13 Binex Co., Ltd.
11.13.1 Binex Co., Ltd. Company Details
11.13.2 Binex Co., Ltd. Business Overview
11.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Introduction
11.13.4 Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.13.5 Binex Co., Ltd. Recent Development
11.14 AbbVie Inc.
11.14.1 AbbVie Inc. Company Details
11.14.2 AbbVie Inc. Business Overview
11.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Introduction
11.14.4 AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.14.5 AbbVie Inc. Recent Development
11.15 WuXi Biologics.
11.15.1 WuXi Biologics. Company Details
11.15.2 WuXi Biologics. Business Overview
11.15.3 WuXi Biologics. Biopharmaceutical CMO & CRO Introduction
11.15.4 WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021)
11.15.5 WuXi Biologics. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics
Table 3. Key Players of Biosimilars
Table 4. Global Biopharmaceutical CMO & CRO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biopharmaceutical CMO & CRO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biopharmaceutical CMO & CRO Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biopharmaceutical CMO & CRO Market Share by Regions (2016-2021)
Table 8. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biopharmaceutical CMO & CRO Market Share by Regions (2022-2027)
Table 10. Biopharmaceutical CMO & CRO Market Trends
Table 11. Biopharmaceutical CMO & CRO Market Drivers
Table 12. Biopharmaceutical CMO & CRO Market Challenges
Table 13. Biopharmaceutical CMO & CRO Market Restraints
Table 14. Global Biopharmaceutical CMO & CRO Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biopharmaceutical CMO & CRO Market Share by Players (2016-2021)
Table 16. Global Top Biopharmaceutical CMO & CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO & CRO as of 2020)
Table 17. Ranking of Global Top Biopharmaceutical CMO & CRO Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biopharmaceutical CMO & CRO Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biopharmaceutical CMO & CRO Product Solution and Service
Table 21. Date of Enter into Biopharmaceutical CMO & CRO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biopharmaceutical CMO & CRO Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2016-2021)
Table 25. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biopharmaceutical CMO & CRO Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biopharmaceutical CMO & CRO Revenue Market Share by Application (2016-2021)
Table 29. Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biopharmaceutical CMO & CRO Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biopharmaceutical CMO & CRO Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biopharmaceutical CMO & CRO Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biopharmaceutical CMO & CRO Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biopharmaceutical CMO & CRO Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biopharmaceutical CMO & CRO Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biopharmaceutical CMO & CRO Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biopharmaceutical CMO & CRO Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biopharmaceutical CMO & CRO Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biopharmaceutical CMO & CRO Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biopharmaceutical CMO & CRO Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biopharmaceutical CMO & CRO Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biopharmaceutical CMO & CRO Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biopharmaceutical CMO & CRO Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biopharmaceutical CMO & CRO Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biopharmaceutical CMO & CRO Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biopharmaceutical CMO & CRO Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biopharmaceutical CMO & CRO Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biopharmaceutical CMO & CRO Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biopharmaceutical CMO & CRO Market Size by Country (2022-2027) & (US$ Million)
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Biopharmaceutical CMO & CRO Product
Table 64. Lonza Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. Boehringer Ingelheim GmbH Company Details
Table 67. Boehringer Ingelheim GmbH Business Overview
Table 68. Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Product
Table 69. Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 70. Boehringer Ingelheim GmbH Recent Development
Table 71. Rentschler Biotechnologie GmbH Company Details
Table 72. Rentschler Biotechnologie GmbH Business Overview
Table 73. Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Product
Table 74. Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 75. Rentschler Biotechnologie GmbH Recent Development
Table 76. Inno Biologics Sdn Bhd Company Details
Table 77. Inno Biologics Sdn Bhd Business Overview
Table 78. Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Product
Table 79. Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 80. Inno Biologics Sdn Bhd Recent Development
Table 81. JRS Pharma (Celonic GmbH) Company Details
Table 82. JRS Pharma (Celonic GmbH) Business Overview
Table 83. JRS Pharma (Celonic GmbH) Biopharmaceutical CMO & CRO Product
Table 84. JRS Pharma (Celonic GmbH) Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 85. JRS Pharma (Celonic GmbH) Recent Development
Table 86. BIOMEVA GmbH Company Details
Table 87. BIOMEVA GmbH Business Overview
Table 88. BIOMEVA GmbH Biopharmaceutical CMO & CRO Product
Table 89. BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 90. BIOMEVA GmbH Recent Development
Table 91. ProBioGen Company Details
Table 92. ProBioGen Business Overview
Table 93. ProBioGen Biopharmaceutical CMO & CRO Product
Table 94. ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 95. ProBioGen Recent Development
Table 96. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
Table 97. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Business Overview
Table 98. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 99. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
Table 100. TOYOBO CO., LTD Company Details
Table 101. TOYOBO CO., LTD Business Overview
Table 102. TOYOBO CO., LTD Biopharmaceutical CMO & CRO Product
Table 103. TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 104. TOYOBO CO., LTD Recent Development
Table 105. Samsung BioLogics Company Details
Table 106. Samsung BioLogics Business Overview
Table 107. Samsung BioLogics Biopharmaceutical CMO & CRO Product
Table 108. Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 109. Samsung BioLogics Recent Development
Table 110. Patheon Company Details
Table 111. Patheon Business Overview
Table 112. Patheon Biopharmaceutical CMO & CRO Product
Table 113. Patheon Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 114. Patheon Recent Development
Table 115. CMC Biologics Company Details
Table 116. CMC Biologics Business Overview
Table 117. CMC Biologics Biopharmaceutical CMO & CRO Product
Table 118. CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 119. CMC Biologics Recent Development
Table 120. Binex Co., Ltd. Company Details
Table 121. Binex Co., Ltd. Business Overview
Table 122. Binex Co., Ltd. Biopharmaceutical CMO & CRO Product
Table 123. Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 124. Binex Co., Ltd. Recent Development
Table 125. AbbVie Inc. Company Details
Table 126. AbbVie Inc. Business Overview
Table 127. AbbVie Inc. Biopharmaceutical CMO & CRO Product
Table 128. AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 129. AbbVie Inc. Recent Development
Table 130. WuXi Biologics. Company Details
Table 131. WuXi Biologics. Business Overview
Table 132. WuXi Biologics. Biopharmaceutical CMO & CRO Product
Table 133. WuXi Biologics. Revenue in Biopharmaceutical CMO & CRO Business (2016-2021) & (US$ Million)
Table 134. WuXi Biologics. Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical CMO & CRO Market Share by Type: 2020 VS 2027
Figure 2. Biologics Features
Figure 3. Biosimilars Features
Figure 4. Global Biopharmaceutical CMO & CRO Market Share by Application: 2020 VS 2027
Figure 5. Contract Manufacturing Case Studies
Figure 6. Contract Research Case Studies
Figure 7. Biopharmaceutical CMO & CRO Report Years Considered
Figure 8. Global Biopharmaceutical CMO & CRO Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Biopharmaceutical CMO & CRO Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Biopharmaceutical CMO & CRO Market Share by Regions: 2020 VS 2027
Figure 11. Global Biopharmaceutical CMO & CRO Market Share by Regions (2022-2027)
Figure 12. Global Biopharmaceutical CMO & CRO Market Share by Players in 2020
Figure 13. Global Top Biopharmaceutical CMO & CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical CMO & CRO as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Biopharmaceutical CMO & CRO Revenue in 2020
Figure 15. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2016-2021)
Figure 16. Global Biopharmaceutical CMO & CRO Revenue Market Share by Type (2022-2027)
Figure 17. North America Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Biopharmaceutical CMO & CRO Market Share by Type (2016-2027)
Figure 19. North America Biopharmaceutical CMO & CRO Market Share by Application (2016-2027)
Figure 20. North America Biopharmaceutical CMO & CRO Market Share by Country (2016-2027)
Figure 21. United States Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Biopharmaceutical CMO & CRO Market Share by Type (2016-2027)
Figure 25. Europe Biopharmaceutical CMO & CRO Market Share by Application (2016-2027)
Figure 26. Europe Biopharmaceutical CMO & CRO Market Share by Country (2016-2027)
Figure 27. Germany Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Region (2016-2027)
Figure 37. China Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Biopharmaceutical CMO & CRO Market Share by Type (2016-2027)
Figure 45. Latin America Biopharmaceutical CMO & CRO Market Share by Application (2016-2027)
Figure 46. Latin America Biopharmaceutical CMO & CRO Market Share by Country (2016-2027)
Figure 47. Mexico Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Country (2016-2027)
Figure 53. Turkey Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Biopharmaceutical CMO & CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Lonza Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 57. Boehringer Ingelheim GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 58. Rentschler Biotechnologie GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 59. Inno Biologics Sdn Bhd Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 60. JRS Pharma (Celonic GmbH) Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 61. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 62. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 63. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 64. TOYOBO CO., LTD Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 65. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 66. Patheon Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 67. CMC Biologics Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 68. Binex Co., Ltd. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 69. AbbVie Inc. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 70. WuXi Biologics. Revenue Growth Rate in Biopharmaceutical CMO & CRO Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---